Krystal Biotech, Inc.
KRYSBiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001711279
Revenue FY2025
$0.39B
Net Income
$0.21B
EPS (Basic)
$7.08
Net Margin
52.6%
ROE
16.8%
Total Equity
$1.22B
Shares Out
30M
Krystal Biotech, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 7 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Torray Funds
Torray
$4.5M
0.6%
+1.0%
OrbiMed Advisors
OrbiMed Advisors
$30.9M
0.2%
+20.4%
Capital World Investors
Capital World Investors
$289.1M
0.0%
(5.7%)
Renaissance Technologies
Renaissance Technologies
$22.2M
0.0%
+521.7%
Bridgewater Associates
Bridgewater Associates
$20.3M
0.0%
+17.5%
WCM Investment Management
WCM Investment Management
$6.0M
0.0%
NEW
Alps Advisors
Alps Advisors
$0.8M
0.0%
+1.8%
Insider Transactions
Reading stored insider transactions…